In Phase III studies, Tonmya showed significantly superior analgesic effects in fibromyalgia patients versus placebo. The sublingual pill also led to better clinical outcomes.
In Phase III studies, Tonmya showed significantly superior analgesic effects in fibromyalgia patients versus placebo. The sublingual pill also led to better clinical outcomes.